Fig. 1
From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia

Distribution of cost difference between hypoglycaemia and controls (80 year time horizon)
From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia
Distribution of cost difference between hypoglycaemia and controls (80 year time horizon)